Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Mar 23 (3): 707-13.
Huang C-N, Huang S-P, Pao J-B, Chang T-Y, Lan Y-H, Lu T-L, Lee H-Z, Juang S-H, Wu P-P, Pu Y-S, Hsieh C-J, Bao B
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 18, 2019
- Content source: